180 likes | 462 Views
Szeged, December 12, 2011. Genotype-phenotype correlation In PKU. Introduction. HPA – BH4-responsive – classic atypical (BH4-dependent) Severity depends partially on the mutation of PAH enzyme
E N D
Szeged, December 12, 2011. Genotype-phenotype correlation In PKU
Introduction • HPA – BH4-responsive – classic atypical (BH4-dependent) • Severity depends partially on the mutation of PAH enzyme • Genotype correlates with the metabolic phenotype in most of the cases – homozygous, severe null mutations • … or „mild” mutations • Most of the patients are compound heterozygous (or – in Hungary - R408W homozygous) • There are significant genotype-phenotype inconsistencies between identical PAH mutation bearing patients • So the PKU/HPA phenotype manifestation is more complex than it could be predictable based on the Mendelian inheritance of the mutated alleles
PAH enzyme N-terminal regulatory domain: AA 1–142 Catalytic domain: AA 143–410 C-terminal domain: AA 411–452 → tetramerization
PAH gene mutations www.pahdb.mcgill.ca • 12q22-q24.1, 13 exon • 564 mutation
BH4-responsive PAH mutations • ~70 known mutation • Mostly point-mutation (never splice, insertion or deletion) • Mostly in the catalytic domain, but not in the cofactor-binding site
Our cases: null mutations • Since 2006 we could not have the patients' DNA sequenced • 52 patients' DNA sequence and mutations are known • Classic PKU: null mutations
Non-null mutations Trefz et al. J Inherit Metab Dis (2009) 32:22–26
Same genotype – different BH4-responsiveness Y414C (mild)/R408W (null) → moderate PKU? BH4 loading with 20 mg/kg bw in 3 patients, all genotype Y414C/R408W. Lindner M et al, Mol Genet Metab 2001; 73:104-106.
Genotype-phenotype in PKU Pathogenic mutation phenotype 1 phenotype 2 phenotype 3 • Genetically determined factors: other intragenic differences, polymorphisms modifying genes: aminoacid transport, competition, metabolism, excretion Non-genetically determined factors
Conclusion • Confirming the genotype may help in the judgement and predicition of the severity of the disease • There are significant genotype-phenotype inconsistencies between similar PAH mutation bearing patients: mainly the regulatory domain mutations lead to unpredictable phenotype, in the cases of compound heterozygosy • BH4-loading test result may vary in a patient - intracellular environment, metabolic status influence the mutated enzyme activity • The standard(ized) Phe+BH4 loading test is the gold standard for planning the treatment!